160 related articles for article (PubMed ID: 28270441)
21. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
22. Mixed chimerism and growth factors augment β cell regeneration and reverse late-stage type 1 diabetes.
Wang M; Racine JJ; Song X; Li X; Nair I; Liu H; Avakian-Mansoorian A; Johnston HF; Liu C; Shen C; Atkinson M; Todorov I; Kandeel F; Forman S; Wilson B; Zeng D
Sci Transl Med; 2012 May; 4(133):133ra59. PubMed ID: 22572882
[TBL] [Abstract][Full Text] [Related]
23. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
[TBL] [Abstract][Full Text] [Related]
24. Rapamycin/GABA combination treatment ameliorates diabetes in NOD mice.
He S; Zhang Y; Wang D; Tao K; Zhang S; Wei L; Chen Q
Mol Immunol; 2016 May; 73():130-7. PubMed ID: 27082922
[TBL] [Abstract][Full Text] [Related]
25. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
Reddy S; Young M; Poole CA; Ross JM
Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
[TBL] [Abstract][Full Text] [Related]
26. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
[TBL] [Abstract][Full Text] [Related]
27. Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice.
Gagliani N; Jofra T; Posgai AL; Atkinson MA; Battaglia M
PLoS One; 2015; 10(11):e0142318. PubMed ID: 26580221
[TBL] [Abstract][Full Text] [Related]
28. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
Serreze DV; Niens M; Kulik J; DiLorenzo TP
Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes.
Hotta M; Tashiro F; Ikegami H; Niwa H; Ogihara T; Yodoi J; Miyazaki J
J Exp Med; 1998 Oct; 188(8):1445-51. PubMed ID: 9782121
[TBL] [Abstract][Full Text] [Related]
30. Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats.
Jahan H; Choudhary MI; Manzoor M; Khan KM; Perveen S; Atta-Ur-Rahman
Chem Biol Interact; 2017 Aug; 273():237-244. PubMed ID: 28625491
[TBL] [Abstract][Full Text] [Related]
31. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
[TBL] [Abstract][Full Text] [Related]
32. Administration of recombinant human thioredoxin-1 significantly delays and prevents autoimmune diabetes in nonobese diabetic mice through modulation of autoimmunity.
Chernatynskaya AV; Looney B; Hu H; Zhu X; Xia CQ
Diabetes Metab Res Rev; 2011 Nov; 27(8):809-12. PubMed ID: 22069264
[TBL] [Abstract][Full Text] [Related]
33. Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice.
Stosić-Grujicić S; Cvjetićanin T; Stojanović I
Mol Immunol; 2009 Nov; 47(1):79-86. PubMed ID: 19211146
[TBL] [Abstract][Full Text] [Related]
34. Protective response against type 1 diabetes in nonobese diabetic mice after coimmunization with insulin and DNA encoding proinsulin.
Zhang W; Jin H; Hu Y; Yu Y; Li X; Ding Z; Kang Y; Wang B
Hum Gene Ther; 2010 Feb; 21(2):171-8. PubMed ID: 19788384
[TBL] [Abstract][Full Text] [Related]
35. Effects of seishin-renshi-in and Gymnema sylvestre on insulin resistance in streptozotocin-induced diabetic rats.
Tominaga M; Kimura M; Sugiyama K; Abe T; Igarashi K; Igarashi M; Eguchi H; Sekikawa A; Ogawa A; Manaka H
Diabetes Res Clin Pract; 1995 Jul; 29(1):11-7. PubMed ID: 8593754
[TBL] [Abstract][Full Text] [Related]
36. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z
Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of Prosopis glandulosa as antidiabetic treatment in rat models of diabetes and insulin resistance.
George C; Lochner A; Huisamen B
J Ethnopharmacol; 2011 Sep; 137(1):298-304. PubMed ID: 21645608
[TBL] [Abstract][Full Text] [Related]
38. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
39. P2X7 receptor knockout prevents streptozotocin-induced type 1 diabetes in mice.
Vieira FS; Nanini HF; Takiya CM; Coutinho-Silva R
Mol Cell Endocrinol; 2016 Jan; 419():148-57. PubMed ID: 26483196
[TBL] [Abstract][Full Text] [Related]
40. Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats.
Wang L; Xu Y; Li H; Lei H; Guan R; Gao Z; Xin Z
J Cell Mol Med; 2015 May; 19(5):960-9. PubMed ID: 25781208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
